Antimicrobial resistance: Charles Darwin was right; India’s drug policy isn’t

The increasing threat of antimicrobial resistance (AMR) in India has prompted experts to emphasize the need for a robust drug policy. The article highlights how antibiotics act not just as medications, but as evolutionary forces that can significantly alter microbial ecosystems. As these medications are widely used, particularly in agriculture and human health, bacteria evolve rapidly, leading to resistance that poses serious public health challenges. Despite the urgency of the situation, India's current drug policy appears to lag in addressing these critical issues effectively. Experts argue that a re-evaluation of antibiotic usage, along with improved regulatory measures, is essential for combating AMR. The situation calls for a holistic approach that includes education on responsible antibiotic use, enhanced surveillance of resistant strains, and a shift towards alternative therapies. The article draws parallels with Darwinian principles, stressing that just as species adapt to their environment, microbes will continue to evolve in response to antibiotics. Therefore, it is imperative for policymakers to adopt strategies that not only mitigate the immediate effects of AMR but also prevent its escalation in the future, ensuring public health safety and preserving the efficacy of existing antibiotics.